Skip to content

Palliative effect of climacteric disorder by using wave motion equipment "RAYOCOMP" (preliminary clinical trial)

Palliative effect of climacteric disorder by using wave motion equipment "RAYOCOMP" (preliminary clinical trial): single blinded study - Palliative effect of climacteric disorder by using wave motion equipment "RAYOCOMP" (preliminary clinical trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048460
Enrollment
3
Registered
2022-07-29
Start date
2022-07-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult female

Interventions

Conduct the basic program once every two days Conduct the another program &quot
once every two days Conduct the another program &quot
C&quot
once every two days

Sponsors

Japan Clinical Trial Association
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Subjects with climacteric disorder

Exclusion criteria

Exclusion criteria: 1.Subjects who started taking medicines for menopausal symptoms within a month 2.Subjects who are planning to start new use / intake of medicines / health foods related to menopausal symptoms during the test period 3.Subjects who are judged as unsuitable for the study by the investigator for the other reason

Design outcomes

Primary

MeasureTime frame
SMI, blood test

Countries

Japan

Contacts

Public ContactTakeshi Kaneko

Japan Clinical Trial Association N.A.

info@yakujihou.org0364574666

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026